Bayer takeover of Monsanto would create a global giant

Bayer’s potential acquisition of Monsanto Co. would create a giant seed and farm chemical company with a strong footprint in the U.S., Europe and Asia, combining two businesses with complementary geographical focus.

But Bayer might have to shed part of its business because of antitrust concerns. And the price tag on any deal would be huge: Monsanto’s market value is around $42 billion.

Germany-based Bayer said Thursday in a short statement that its executives had met recently with their Monsanto counterparts “to privately discuss a negotiated acquisition” of the specialist in genetically modified crop seeds.

The news of a potentially costly deal sent Bayer shares tumbling 8.2%. Monsanto shares climbed 3.5%.

Both companies are familiar brands on farms around the globe. Bayer, whose farm business produces seeds as well as compounds to kill weeds, bugs and fungus, said the proposed acquisition would help it “create a leading integrated agriculture business.”

Monsanto, based in St. Louis, said it was reviewing Bayer’s proposal. Neither company gave other details.

The possible deal had been rumored for a week, but these were the first comments from either company.

“A combination of both companies would create $67 billion of annual sales and the world’s largest seed and crop-chemical company,” analyst Ulrich Huwald at Warburg Research wrote in a research note to investors. “However, the question is if Monsanto would be interested in a deal.”

Huwald said that “the businesses are geographically complementary, with Monsanto having a strong presence in North America and Bayer in Europe and Asia.”

A combination of the two would have 28% of the global market for pesticides and a strong presence in the U.S. corn and soybean seed business.

Huwald said that the two companies do overlap in their vegetable and cotton seed business, which could require divestments due to antitrust issues. Bayer might also have to sell parts of its weed killer business.

See the most-read stories this hour >>

Antitrust regulators scrutinize mergers and takeovers and have the authority to block them if they hinder free-market competition. If companies get too much control over a market, they can charge higher prices and have fewer incentives to innovate.

News of the talks follows a wave of consolidation in the chemical industry: DuPont and Dow Chemical agreed to combine last year, and ChemChina agreed to buy Syngenta of Switzerland in March after Monsanto’s own bid for its Basel-based rival failed.

Monsanto has some 20,000 employees and produces seeds for fruits, vegetables and other crops including corn, soybeans and cotton, as well as the popular weed killer Roundup.

Its sales have suffered recently as falling crop prices have reduced farmers’ spending on its genetically enhanced seeds. And the strong U.S. dollar has meant its products are more expensive overseas.

Bayer, headquartered in Leverkusen, Germany, specializes in healthcare and agriculture. It employs about 117,000 people worldwide and had sales last year of $52.22 billion.

ALSO

Education and healthcare are ripe for start-ups, AOL co-founder says

Sports Authority to close all of its stores, including dozens in California

Thanks to new federal rules, some mid-level managers are in line for a big raise

UPDATES:

1:32 p.m.: This article was updated with Monsanto shares’ movement.

This article was originally published at 1:03 p.m.